Hedge Fund - DAFNA Capital Management
Ascendis Pharma A/S (ASND)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $12,530,832 | 3.55% | 80,398 | $142.85 |
| 2 | 2024 - Q4 (2024-12-31) | $14,228,883 | 3.61% | 103,355 | $131.48 |
| 3 | 2024 - Q3 (2024-09-30) | $13,373,995 | 3.15% | 89,572 | $135.05 |
| 4 | 2024 - Q2 (2024-06-30) | $11,042,961 | 2.63% | 80,972 | $136.06 |
| 5 | 2024 - Q1 (2024-03-31) | $13,978,992 | 3.18% | 92,472 | $142.72 |
| 6 | 2023 - Q4 (2023-12-31) | $15,551,298 | 3.72% | 123,472 | $99.70 |
| 7 | 2023 - Q3 (2023-09-30) | $12,754,892 | 3.96% | 136,212 | $93.55 |
| 8 | 2023 - Q2 (2023-06-30) | $12,067,671 | 3.29% | 135,212 | $87.09 |
| 9 | 2023 - Q1 (2023-03-31) | $14,497,431 | 4.34% | 135,212 | $114.40 |
| 10 | 2022 - Q4 (2022-12-31) | $15,902,792 | 4.47% | 130,212 | $116.10 |
| 11 | 2022 - Q3 (2022-09-30) | $14,014,000 | 3.76% | 135,712 | $94.81 |
| 12 | 2022 - Q2 (2022-06-30) | $12,941,000 | 3.52% | 139,212 | $94.25 |
| 13 | 2022 - Q1 (2022-03-31) | $3,593,000 | 0.93% | 30,612 | $115.81 |
| 14 | 2021 - Q4 (2021-12-31) | $1,480,000 | 0.37% | 11,000 | $148.75 |
| 15 | 2021 - Q3 (2021-09-30) | $0 | 0% | 0 | $136.86 |
| 16 | 2021 - Q2 (2021-06-30) | $939,000 | 0.19% | 7,137 | $133.25 |
| 17 | 2021 - Q1 (2021-03-31) | $2,995,000 | 0.71% | 23,237 | $151.98 |
| 18 | 2020 - Q4 (2020-12-31) | $3,875,000 | 1.15% | 23,237 | $165.37 |
| 19 | 2020 - Q3 (2020-09-30) | $4,512,000 | 1.46% | 29,237 | $143.74 |
| 20 | 2020 - Q2 (2020-06-30) | $2,106,000 | 0.6% | 14,237 | $137.30 |
| 21 | 2020 - Q1 (2020-03-31) | $3,799,000 | 1.58% | 33,737 | $129.93 |
| 22 | 2019 - Q4 (2019-12-31) | $3,909,000 | 1.34% | 28,100 | $111.10 |
| 23 | 2019 - Q3 (2019-09-30) | $5,825,000 | 2.19% | 60,480 | $111.55 |
| 24 | 2019 - Q2 (2019-06-30) | $6,838,000 | 2.57% | 59,380 | $119.66 |
| 25 | 2019 - Q1 (2019-03-31) | $5,224,000 | 2.25% | 44,380 | $87.57 |
| 26 | 2018 - Q4 (2018-12-31) | $4,839,000 | 2.4% | 77,242 | $62.83 |
| 27 | 2018 - Q3 (2018-09-30) | $5,473,000 | 2.24% | 77,242 | $68.83 |
| 28 | 2018 - Q2 (2018-06-30) | $4,906,000 | 2.29% | 73,745 | $65.76 |
| 29 | 2018 - Q1 (2018-03-31) | $5,183,000 | 2.52% | 79,245 | $56.20 |
| 30 | 2017 - Q4 (2017-12-31) | $4,993,000 | 2.68% | 124,639 | $36.36 |
| 31 | 2017 - Q3 (2017-09-30) | $2,618,000 | 1.62% | 72,226 | $28.70 |
| 32 | 2017 - Q2 (2017-06-30) | $922,000 | 0.65% | 33,214 | $26.42 |
| 33 | 2017 - Q1 (2017-03-31) | $510,000 | 0.43% | 18,214 | $25.27 |
| 34 | 2016 - Q4 (2016-12-31) | $1,073,000 | 0.94% | 53,000 | $19.97 |
| 35 | 2016 - Q3 (2016-09-30) | $618,000 | 0.43% | 30,750 | $16.51 |
| 36 | 2016 - Q2 (2016-06-30) | $707,000 | 0.56% | 53,241 | $15.41 |
| 37 | 2016 - Q1 (2016-03-31) | $988,000 | 0.85% | 53,241 | $17.76 |
| 38 | 2015 - Q4 (2015-12-31) | $975,000 | 0.86% | 53,241 | $17.53 |
| 39 | 2015 - Q3 (2015-09-30) | $942,000 | 0.93% | 53,241 | $19.47 |
| 40 | 2015 - Q2 (2015-06-30) | $1,654,000 | 1.39% | 93,541 | $17.50 |
| 41 | 2015 - Q1 (2015-03-31) | $1,623,000 | 1.24% | 93,541 | $18.18 |
The displayed share prices are average quarterly stock market prices.